ArticleBiochemistry and biophysics reports2026
A colorimetric readout based on the PrestoBlue® dye as an objective method for measuring neutralizing antibodies against influenza virus in human serum samples.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza is an infectious respiratory disease that has significant morbidity and a high mortality rate. The immune responses induced against both seasonal and potentially pandemic strains of the influenza virus are of fundamental importance. The microneutralization (MN) assay is an extremely important virological test for the evaluation of vaccines, and therefore of the antibody response. However, there is not always a correspondence between the results obtained from the same samples, owing to the difficult readout of the cytopathic effect (CPE) in the case of live viruses and the subjectivity of interpretation by operators. Moreover, if the test is combined with the Enzyme-Linked Immunosorbent Assay (ELISA) technique, the process is laborious. Here, we present a microneutralization assay that uses the PrestoBlue® reagent as a colorimetric CPE-based method. We evaluated the performance of this test on multiple strains of influenza virus by using human serum samples from a commercial panel and comparing both subjective (inverted microscope) and objective (spectrophotometer) readouts. Our results suggest that this colorimetric method for assessing CPE in microneutralization tests is more sensitive than the subjective method, while yielding comparable titers. This assay allows accurate and repeatable reading of the results, thereby reducing the possible uncertainty of the readout and speeding up the process.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.